Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief
Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…
AdaptHealth Diabetes Health Divestiture to Cardinal Health | Lucid Diligence Brief
AdaptHealth exits its Diabetes Health business in a $235 million deal as…
Endocrinology Strategic Roundup | June 23–July 20, 2026
Strategic Developments and Competitive Shifts in Endocrinology Coverage Period:…
Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief
Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…
Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief
Nucleai broadened its University of Glasgow collaboration to expand academic…
United Therapeutics’ Thymmune acquisition | Lucid Diligence Brief
United Therapeutics adds Thymmune’s iPSC thymic-cell platform to its…
Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief
Insilico and Takeda test whether Pharma.AI can convert discovery speed into…
Merck KGaA Bio-Techne Deal | Lucid Diligence Brief
Merck KGaA’s US$11.3bn Bio-Techne acquisition tests workflow depth, integration…
DermaSensor AI dermatology devices | Lucid Diligence Brief
AI dermatology devices are advancing beyond validation studies as DermaSensor…
Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief
Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…
Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief
Merck and Protillion partner on AI protein design. Assess milestones, platform…
Intravacc and SynphaBase Conjugate Vaccine Partnership | Lucid Diligence Brief
Can Intravacc and SynphaBase create a streamlined synthetic glycan-to-GMP…